Info/Guidance for Health Care Providers
Guidance and information for various health care settings and services from the N.C. Department of Health and Human Services.
Can't find what you're looking for? Search the CDC's COVID-19 website.
General Guidance
Accessibility
- Accessibility Tips, Tricks and FAQs (Spanish)
- Advancing Equity through Language, Communication and Physical Access (Spanish)
- Accessibility at Drive-Thru Medical Sites
- Historically Marginalized Populations Engagement Toolkit
- Americans with Disabilities Act (ADA) and Section 504 Rehabilitation Act (RA) Protections during COVID-19
For Providers with Deaf, Hard of Hearing and DeafBlind Patients
Behavioral Health
- Resources: COVID-19 and Behavioral Health
- Strategies for Counties to Support Behavior Health and IDD Services
- COVID Letter to LME-MCOs
- NCDHHS Outpatient and Crisis System Providers
- NCDHHS Behavioral Health/IDD Day Program and Facility-Based Crisis Guidance (June 10, 2020)
- NC Innovations and TBI Waiver Appendix K FAQs (May 6, 2020)
Infection Prevention Guidance
NCDHHS refers to CDC and CMS guidance:
- CDC Information for Healthcare Settings
- CDC - Managing HCP with SARS-CoV-2 Infection or Exposure
- CDC - Mitigating Staff Shortages
- CMS - QSO Nursing Home Visitation
Regional Infection Prevention Teams
- RIPS Team Program Overview
- Comprehensive RIPS ICAR
- Environmental Rounds Tool - for use in small family care/group homes
Pregnancy and Child Health
- COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics
- ACOG Practice Advisory General Information Regarding Pregnant Individuals and COVID-19
- CDC Pediatric Healthcare Providers Caring for Children
- Multisystem Inflammatory Syndrome in Children (MIS-C)
Testing
General Guidance
- Testing Info for Partners and Providers
- Collecting COVID-19 Samples: Guidance for Non-Clinical Community Partners
- Request Specimen Collection Supplies
- Testing Surge Workgroup
- CDC - Healthcare Worker Guidance on COVID-19 Testing
- CDC - COVID-19 Data Tracker
(Go to Long-Term Care Facilities for setting-specific testing guidance)
Laboratories
Reporting
- Facilities Reporting Test Results
- 10A NCAC 41A .0107- Reporting of COVID-19 Test Results
- Federal Guidance for Reporting of COVID-19 Test Results
- NCDHHS Guidance for Reporting COVID-19 Diagnostic Test Results
- Provider Memo: Sequencing and Breakthrough Cases
- Antigen Results - Downloadable Excel Spreadsheet
Statewide Standing Orders for Testing
- Order for COVID-19 Diagnostic Testing (March 14, 2024)
- Order to Allow Pharmacists to Dispense Over the Counter At-Home COVID-19 Tests (Jan. 14, 2022)
Statewide Standing Order Recissions for Therapeutics
- Intravenous Administration of Bebtelovimab Monoclonal Antibodies (Nov. 30, 2022)
- Intravenous Administration of Sotrovimab Monoclonal Antibodies (April 6, 2022)
- Subcutaneous Administration of Casirivimab/Imdevimab (REGEN-COV) Monoclonal Antibodies (Jan. 24, 2022)
- Intravenous Administration of Casirivimab/Imdevimab (REGEN-COV) Monoclonal Antibodies (Jan. 24, 2022)
- Intravenous Administration of Bamlanivimab/Etesevimab Monoclonal Antibodies (Jan. 24, 2022)
Vaccines
General Guidance
- NCDHHS COVID-19 Vaccine Provider Guidance (July 29, 2022)
- CDC - COVID-19 Vaccination Planning and Partnerships
- Secretarial Order 8 (March 3, 2021) - Allows licensed dentists to administer COVID-19 vaccinations
- Coadministration of the COVID-19 Vaccine (Sept. 24, 2021)
Statewide Standing Orders for Vaccine Administration
Moderna Vaccines
- Moderna COVID-19 Vaccine for 6 Months-11 Years (Jan. 22, 2024)
- Moderna COVID-19 Vaccine for 12 Years and Older (March 6, 2024)
Pfizer Vaccines
- Pfizer-BioNTech COVID-19 Vaccine for 6 Months-11 Years (Jan. 22, 2024)
- Pfizer-BioNTech COVID-19 Vaccine for 12 Years and Older (March 6, 2024)
Novavax Vaccine
- Novavax COVID-19 Vaccine for 12 Years and Older (March 6, 2024)